TY - JOUR AU - Govender, N. P. AU - Roy, M. AU - Mendes, J. F. AU - Zulu, T. G. AU - Chiller, T. M. AU - Karstaedt, A. S. PY - 2015 DA - 2015// TI - Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa JO - HIV Med VL - 16 UR - https://doi.org/10.1111/hiv.12245 DO - 10.1111/hiv.12245 ID - Govender2015 ER - TY - JOUR AU - Longley, N. AU - Jarvis, J. N. AU - Meintjes, G. AU - Boulle, A. AU - Cross, A. AU - Kelly, N. PY - 2016 DA - 2016// TI - Cryptococcal antigen screening in persons initiating ART in South Africa: a prospective cohort study JO - Clin Infect Dis VL - 62 UR - https://doi.org/10.1093/cid/civ936 DO - 10.1093/cid/civ936 ID - Longley2016 ER - TY - JOUR AU - Rajasingham, R. AU - Smith, R. M. AU - Park, B. J. AU - Jarvis, J. N. AU - Govender, N. P. AU - Chiller, T. M. PY - 2017 DA - 2017// TI - Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis JO - Lancet Infect Dis VL - 17 UR - https://doi.org/10.1016/S1473-3099(17)30243-8 DO - 10.1016/S1473-3099(17)30243-8 ID - Rajasingham2017 ER - TY - JOUR AU - French, N. AU - Gray, K. AU - Watera, C. AU - Nakiyingi, J. AU - Lugada, E. AU - Moore, M. PY - 2002 DA - 2002// TI - Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults JO - AIDS VL - 16 UR - https://doi.org/10.1097/00002030-200205030-00009 DO - 10.1097/00002030-200205030-00009 ID - French2002 ER - TY - JOUR AU - Larson, B. A. AU - Rockers, P. C. AU - Bonawitz, R. AU - Sriruttan, C. AU - Glencross, D. K. AU - Cassim, N. PY - 2016 DA - 2016// TI - Screening HIV-infected persons with low CD4 counts for cryptococcal antigenemia prior to initiation of antiretroviral therapy: cost effectiveness of alternative screening strategies in South Africa JO - PLoS One VL - 11 UR - https://doi.org/10.1371/journal.pone.0158986 DO - 10.1371/journal.pone.0158986 ID - Larson2016 ER - TY - JOUR AU - Awotiwon, A. A. AU - Johnson, S. AU - Rutherford, G. W. AU - Meintjes, G. AU - Eshun-Wilson, I. PY - 2018 DA - 2018// TI - Primary antifungal prophylaxis for cryptococcal disease in HIV-positive people JO - Cochrane Database Syst Rev VL - 2018 ID - Awotiwon2018 ER - TY - JOUR AU - Jarvis, J. N. AU - Meintjes, G. AU - Williams, A. AU - Brown, Y. AU - Crede, T. AU - Harrison, T. S. PY - 2010 DA - 2010// TI - Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases JO - BMC Infect Dis VL - 10 UR - https://doi.org/10.1186/1471-2334-10-67 DO - 10.1186/1471-2334-10-67 ID - Jarvis2010 ER - TY - JOUR AU - Sathyanarayanan, V. AU - Razak, A. AU - Chakraborty, J. PY - 2010 DA - 2010// TI - Clinical profile of disseminated cryptococcal infection – a case series JO - Asian Pacific Trop Med VL - 3 UR - https://doi.org/10.1016/S1995-7645(10)60197-6 DO - 10.1016/S1995-7645(10)60197-6 ID - Sathyanarayanan2010 ER - TY - JOUR AU - Kaplan, J. E. AU - Vallabhaneni, S. AU - Smith, R. M. AU - Chideya-chihota, S. AU - Chehab, J. AU - Park, B. PY - 2015 DA - 2015// TI - Cryptococcal antigen screening and early antifungal treatment to prevent cryptococcal meningitis: a review of the literature JO - J Acquir Immune Defic Syndr VL - 68 UR - https://doi.org/10.1097/QAI.0000000000000484 DO - 10.1097/QAI.0000000000000484 ID - Kaplan2015 ER - TY - JOUR AU - Beyene, T. AU - Woldeamanuel, Y. AU - Asrat, D. AU - Ayana, G. AU - Boulware, D. R. PY - 2013 DA - 2013// TI - Comparison of cryptococcal antigenemia between antiretroviral naïve and antiretroviral experienced HIV positive persons at two hospitals in Ethiopia JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0075585 DO - 10.1371/journal.pone.0075585 ID - Beyene2013 ER - TY - JOUR AU - Jarvis, J. N. AU - Lawn, S. D. AU - Vogt, M. AU - Bangani, N. AU - Wood, R. AU - Harrison, T. S. PY - 2009 DA - 2009// TI - Screening for cryptococcal antigenemia in persons accessing an antiretroviral treatment program in South Africa JO - Clin Infect Dis VL - 48 UR - https://doi.org/10.1086/597262 DO - 10.1086/597262 ID - Jarvis2009 ER - TY - JOUR AU - Meya, D. AU - Rajasingham, R. AU - Nalintya, E. AU - Tenforde, M. AU - Jarvis, J. N. PY - 2015 DA - 2015// TI - Preventing cryptococcosis shifting the paradigm in the era of highly active antiretroviral therapy JO - Curr Trop Med Rep VL - 2 UR - https://doi.org/10.1007/s40475-015-0045-z DO - 10.1007/s40475-015-0045-z ID - Meya2015 ER - TY - STD TI - World Health Organization. Guidelines for the diagnosis, prevention and management of Cryptococcal disease in HIV-infected adults, adolescents and children. 2018. http://www.who.int/hiv/pub/guidelines/cryptococcal-disease/en/. Accessed 30 Mar 2018. UR - http://www.who.int/hiv/pub/guidelines/cryptococcal-disease/en/ ID - ref13 ER - TY - BOOK PY - 2016 DA - 2016// TI - Joanna Briggs institute reviewers’ manual: 2016 edition PB - The Joanna Briggs Institute CY - Australia ID - ref14 ER - TY - JOUR AU - Higgins, J. P. AU - Altman, D. G. AU - Gotzsche, P. C. AU - Jüni, P. AU - Moher, D. AU - Oxman, A. D. PY - 2011 DA - 2011// TI - The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials JO - BMJ VL - 343 UR - https://doi.org/10.1136/bmj.d5928 DO - 10.1136/bmj.d5928 ID - Higgins2011 ER - TY - STD TI - Temfack E, Bigna JJ, Luma HN, Spijker R, Meintjes G, Jarvis JN, et al. Impact of routine cryptococcal antigen screening and targeted pre-emptive fluconazole therapy in antiretroviral naive HIV-infected adults with less than 100 CD4 cells/μL: a systematic review and meta-analysis. Clin Infect Dis. 2018. https://doi.org/10.1093/cid/ciy567. ID - ref16 ER - TY - JOUR AU - Huang, Y. AU - Huang, X. AU - Luo, Y. AU - Zhou, Y. AU - Tao, X. AU - Chen, H. PY - 2018 DA - 2018// TI - Assessing the efficacy of lopinavir/ritonavir-based preferred and alternative second-line regimens in HIV-infected persons: a meta-analysis of key evidence to support WHO recommendations JO - Front Pharmacol VL - 9 UR - https://doi.org/10.3389/fphar.2018.00890 DO - 10.3389/fphar.2018.00890 ID - Huang2018 ER - TY - JOUR AU - Chariyalertsak, S. AU - Supparatpinyo, K. AU - Sirisanthana, T. AU - Nelson, K. E. PY - 2002 DA - 2002// TI - A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in persons with advanced human immunodeficiency virus infection in Thailand JO - Clin Infect Dis VL - 34 UR - https://doi.org/10.1086/338154 DO - 10.1086/338154 ID - Chariyalertsak2002 ER - TY - JOUR AU - Manfredi, R. AU - Mastroianni, A. AU - Coronado, O. V. AU - Chiodo, F. PY - 1997 DA - 1997// TI - Fluconazole as prophylaxis against fungal infection in persons with advanced HIV infection JO - Arch Intern Med VL - 157 UR - https://doi.org/10.1001/archinte.1997.00440220068009 DO - 10.1001/archinte.1997.00440220068009 ID - Manfredi1997 ER - TY - JOUR AU - Parkes-Ratanshi, R. AU - Wakeham, K. AU - Levin, J. AU - Namusoke, D. AU - Whitworth, J. AU - Coutinho, A. PY - 2011 DA - 2011// TI - Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial JO - Lancet Infect Dis VL - 11 UR - https://doi.org/10.1016/S1473-3099(11)70245-6 DO - 10.1016/S1473-3099(11)70245-6 ID - Parkes-Ratanshi2011 ER - TY - JOUR AU - McKinsey, D. S. AU - Wheat, L. J. AU - Cloud, G. A. AU - Pierce, M. AU - Black, J. R. AU - Bamberger, D. M. PY - 1999 DA - 1999// TI - Itraconazole prophylaxis for fungal infections in persons with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group JO - Clin Infect Dis VL - 28 UR - https://doi.org/10.1086/514744 DO - 10.1086/514744 ID - McKinsey1999 ER - TY - JOUR AU - Meya, D. B. AU - Manabe, Y. C. AU - Castelnuovo, B. AU - Cook, B. A. AU - Elbireer, A. M. AU - Kambugu, A. PY - 2010 DA - 2010// TI - Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings JO - Clin Infect Dis VL - 51 UR - https://doi.org/10.1086/655143 DO - 10.1086/655143 ID - Meya2010 ER - TY - JOUR AU - Kapoor, S. W. AU - Magambo, K. A. AU - Kalluvya, S. E. AU - Fitzgerald, D. W. AU - Peck, R. N. AU - Downs, J. A. PY - 2015 DA - 2015// TI - Six-month outcomes of HIV-infected persons given short-course fluconazole therapy for asymptomatic cryptococcal antigenemia JO - AIDS VL - 29 UR - https://doi.org/10.1097/QAD.0000000000000872 DO - 10.1097/QAD.0000000000000872 ID - Kapoor2015 ER - TY - JOUR AU - Borges, M. A. S. B. AU - Araújo Filho, J. A. AU - Oliveira, B. J. S. AU - Moreira, I. S. AU - Paula, V. V. AU - Bastos, A. L. PY - 2019 DA - 2019// TI - Prospective cohort of AIDS patients screened for cryptococcal antigenaemia, pre-emptively treated and followed in Brazil JO - PLoS One VL - 14 UR - https://doi.org/10.1371/journal.pone.0219928 DO - 10.1371/journal.pone.0219928 ID - Borges2019 ER - TY - STD TI - Ssekitoleko R, Kamya MR, Reingold AL. Primary prophylaxis for cryptococcal meningitis and impact on mortality in HIV: a systematic review and meta-analysis. Future Virol. 2013;8(9). https://doi.org/10.2217/fvl.13.71. ID - ref25 ER - TY - JOUR AU - Ford, N. AU - Shubber, Z. AU - Jarvis, J. N. AU - Chiller, T. AU - Greene, G. AU - Migone, C. PY - 2018 DA - 2018// TI - CD4 cell count threshold for cryptococcal antigen screening of HIV-infected individuals: a systematic review and meta-analysis JO - Clin Infect Dis VL - 66 UR - https://doi.org/10.1093/cid/cix1143 DO - 10.1093/cid/cix1143 ID - Ford2018 ER - TY - STD TI - Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva: World Health Organization. 2015. http://www.who.int/hiv/pub/guidelines/earlyrelease-arv/en. Accessed 29 Sept 2015. UR - http://www.who.int/hiv/pub/guidelines/earlyrelease-arv/en ID - ref27 ER -